Targeting macrophage-related biomarkers, such as specific cytokines (e.g., TNF-α, IL-6) or macrophage surface markers (e.g., CD68), could provide diagnostic tools or therapeutic targets for adenomyosis (19). The gene discussed is CD68; the disease is adenomyosis.